ArticleDiabetologia2018
Clinically meaningful and lasting HbA
Article in Diabetologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.Hormone research in paediatrics · 2024Guideline
- Effect of early glycemic control on HbA1c tracking and development of vascular complications after 5 years of childhood onset type 1 diabetes: Systematic review and meta-analysis.Pediatric diabetes · 2019Pooled it
- Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, Canada.Diabetes, obesity & metabolism · 2026Article
- Social Determinants of Health Impact on Pediatric Type 1 Diabetes Outcomes Early after Diagnosis.Hormone research in paediatrics · 2026Article
- Sustained HbA1c Improvements Over 36 Months in Youth in the Teamwork, Targets, Technology, and Tight Control (4T) Study.The Journal of clinical endocrinology and metabolism · 2026Article
- Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes.Diabetes care · 2025Observational
- ROCKET T1D Remote Patient Monitoring Program: Launching Diabetes Management Habits in New-Onset Diabetes.Clinical diabetes : a publication of the American Diabetes Association · 2025Article
- A Retrospective Cohort Study of Racial/Ethnic and Socioeconomic Disparities in Initiation and Meaningful Use of Continuous Glucose Monitoring Among Youth With Type 1 Diabetes.Journal of diabetes science and technology · 2024Article
- Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes.Nature medicine · 2024Article
- Diabetes Study of Children of Diverse Ethnicity and Race: Study design.Diabetes/metabolism research and reviews · 2024Observational
- Chronic Disease Management of Children Followed with Type 1 Diabetes MellitusJournal of clinical research in pediatric endocrinology · 2023Article
- Roadmap to Continuous Glucose Monitoring Adoption and Improved Outcomes in Endocrinology: The 4T (Teamwork, Targets, Technology, and Tight Control) Program.Diabetes spectrum : a publication of the American Diabetes Association · 2023Article
- ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring.Pediatric diabetes · 2022Article
- ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes.Pediatric diabetes · 2022Article
- Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study.The Journal of clinical endocrinology and metabolism · 2022Article
- Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230.Diabetes care · 2022Article
- A model to design financially sustainable algorithm-enabled remote patient monitoring for pediatric type 1 diabetes care.Frontiers in endocrinology · 2022Article
- A little help from residual β cells has long-lasting clinical benefits.The Journal of clinical investigation · 2021Article
- Glycemic Tracking Before and After Insulin Pump Initiation.Journal of diabetes science and technology · 2020Article
- Factors predicting poor glycemic control in the first two years of childhood onset type 1 diabetes in a cohort from East London, UK: Analyses using mixed effects fractional polynomial models.Pediatric diabetes · 2020Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
Abstract
aims/hypothesisOur objectives were to explore whether the phenomenon of HbA
methodsA total of 4525 individuals diagnosed with type 1 diabetes between 1 January 1995 and 1 May 2015 were identified from The Health Improvement Network (THIN) database. Mixed models were applied to assess the variability of HbA
results4525 individuals diagnosed with type 1 diabetes were identified in THIN over the study period. The greatest difference in mean HbA CONCLUSIONS/
interpretationIn individuals with type 1 diabetes, glycaemic control measured by HbA
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.